Related Experiment Videos
A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication
1Department of Medicine, University of California, School of Medicine, San Francisco 94143.
Immunology
|April 1, 1989
Summary
CD8+ T cells from HIV-infected individuals can suppress HIV replication. This antiviral activity, mediated by a lymphokine or cell contact, varies among patients and may offer strategies for enhancing immune responses.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- Human immunodeficiency virus (HIV) infection is a global health concern.
- Peripheral blood CD8+ T lymphocytes play a role in controlling viral infections.
- Understanding the mechanisms of HIV suppression by immune cells is crucial for therapeutic development.
Purpose of the Study:
- To investigate the antiviral activity of CD8+ T lymphocytes from HIV-infected individuals against HIV replication.
- To identify the factors mediating this suppression.
- To explore potential therapeutic strategies for enhancing anti-HIV immune responses.
Main Methods:
- Isolation of peripheral blood CD8+ T lymphocytes and peripheral blood mononuclear cells (PBMC) from HIV-infected individuals.
- Assay of HIV replication in PBMC.
- Analysis of suppressive activity mediated by CD8+ T cells, including diffusible factors and direct cell contact.
Main Results:
- CD8+ T lymphocytes from HIV-infected individuals demonstrated suppression of HIV replication in PBMC.
- This antiviral activity was partly mediated by a diffusible lymphokine.
- The production of this lymphokine varied among individuals, suggesting intrinsic differences in immune control.
- In some cases, direct contact between CD8+ and infected CD4+ T cells induced viral suppression.
Conclusions:
- Peripheral blood CD8+ T cells possess inherent antiviral properties against HIV.
- The identified suppressive mechanisms, involving lymphokines and cell contact, offer potential targets for therapeutic intervention.
- These findings could pave the way for novel strategies to enhance anti-HIV immune responses in infected individuals.